Cargando…
Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge
Pancreatic cancer is the fourth leading cause of cancer-related deaths in the United States and incidence rates are rising. Both detection and treatment options for pancreatic cancer are limited, providing a less than 5% five-year survival advantage. The need for new biomarkers for early detection a...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586794/ https://www.ncbi.nlm.nih.gov/pubmed/26404380 http://dx.doi.org/10.3390/cancers7030861 |